WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010023196) PIPERIDYLPROPIONAMIDE DERIVATIVES USEFUL FOR THE TREATMENT OF CNS DISORDERS INCLUDING DEPRESSION AND PANIC DISORDER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/023196    International Application No.:    PCT/EP2009/060909
Publication Date: 04.03.2010 International Filing Date: 25.08.2009
IPC:
C07D 211/34 (2006.01), A61K 31/44 (2006.01), A61P 25/00 (2006.01)
Applicants: NEUROSEARCH A/S [DK/DK]; Pederstrupvej 93 DK-2750 Ballerup (DK) (For All Designated States Except US).
PETERS, Dan [SE/DK]; (DK) (For US Only).
REDROBE, John, Paul [GB/DK]; (DK) (For US Only).
NIELSEN, Elsebet, Østergaard [DK/DK]; (DK) (For US Only)
Inventors: PETERS, Dan; (DK).
REDROBE, John, Paul; (DK).
NIELSEN, Elsebet, Østergaard; (DK)
Common
Representative:
NEUROSEARCH A/S [DK/DK]; Patent Department Pederstrupvej 93 DK-2750 Ballerup (DK)
Priority Data:
PA 2008 01210 01.09.2008 DK
61/093,765 03.09.2008 US
Title (EN) PIPERIDYLPROPIONAMIDE DERIVATIVES USEFUL FOR THE TREATMENT OF CNS DISORDERS INCLUDING DEPRESSION AND PANIC DISORDER
(FR) NOUVEAUX DÉRIVÉS DE PIPÉRIDINE-PROPIONAMIDE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DU RECAPTAGE DES NEUROTRANSMETTEURS MONOAMINES
Abstract: front page image
(EN)This invention relates to novel piperidine-4-propionamide derivatives useful as monoamine neurotransmitter re-uptake inhibitors. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
(FR)La présente invention concerne des nouveaux dérivés de pipéridine-4-propionamide utilisés en tant qu'inhibiteurs du recaptage des neurotransmetteurs monoamines. D'autres aspects de l'invention concernent l'utilisation de ces composés dans des méthodes thérapeutiques, ainsi que des compositions pharmaceutiques comprenant les composés décrits dans l'invention.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)